Is Your Paper Ready for Kidney International Supplements?

Kidney International Supplements is not a general nephrology research journal. It is the official publication venue for three specific content types.

KDIGO clinical practice guidelines. The journal's primary content is the production of Kidney Disease: Improving Global Outcomes guidelines, developed by international work groups convened by KDIGO, the nonprofit organization that systematically reviews evidence and produces consensus clinical practice guidance for nephrology, nephrology-adjacent specialties, and primary care physicians managing kidney disease. These guidelines are the source of the journal's citation impact and its reason for existing. Individual researchers cannot submit papers to this process; participation requires invitation to a KDIGO work group.

ISN-organized supplement issues. The International Society of Nephrology coordinates supplement issues focused on specific research programs, epidemiological studies, or thematic topics in global nephrology. Contributions to these supplements are solicited by the organizing group. The supplement model means that all contributors are identified before submissions are open, and the editorial process is managed at the supplement level rather than manuscript by manuscript.

Invited review articles. The journal occasionally publishes comprehensive review articles commissioned by editors in the context of an organized issue. These are not the result of authors proposing reviews independently.

Understanding KDIGO is essential to understanding what Kidney International Supplements actually does. According to the KDIGO organization's process documentation, the guidelines development process involves systematic evidence reviews conducted by international work groups over months or years, followed by public comment periods, and ultimately publication as supplement issues in Kidney International Supplements. The CKD guidelines, AKI guidelines, lupus nephritis guidelines, and hepatitis C guidelines for kidney disease patients are among the most prominent examples.

These guidelines are among the most cited documents in clinical nephrology globally. A single KDIGO guideline supplement can generate thousands of citations over its lifecycle. That citation volume is what drives the journal's impact factor to levels that would seem competitive with standard research journals. The IF number is real, but what it measures is not what researchers typically use impact factor to measure.

The practical implication: if a researcher is evaluating Kidney International Supplements as a potential submission target based on its IF, they are working from a misleading signal. The journal's citation metrics reflect the KDIGO process, not the accessibility or prestige of the journal as a research submission venue.

In a standard journal, individual authors submit manuscripts, editors triage and assign reviewers, and papers are accepted or rejected individually. Kidney International Supplements does not work this way.

In the supplement model, an organizing body (KDIGO, ISN, or a research consortium) proposes a supplement issue to the journal. The proposal is reviewed and approved at the editorial level. Once approved, the organizing body identifies contributors, assigns topics, and coordinates manuscript development. All contributions arrive already embedded in the supplement structure.

This means that the question researchers typically ask ("Is my paper ready for this journal?") does not apply. The relevant question is: "Am I part of an organized supplement issue that is publishing in this journal?" If the answer is no, the journal is not accepting your submission regardless of the quality of the work.

For researchers with standard nephrology research papers, the relevant comparison is between the standard research journals in the field.

Per Kidney International's editorial information, the flagship journal of the ISN accepts approximately 15% of manuscripts and is the most selective dedicated nephrology journal alongside JASN. According to the American Society of Nephrology's author information, CJASN has a higher acceptance rate at approximately 22%, making it more accessible for clinical nephrology research that may not meet JASN's mechanistic depth threshold. AJKD focuses on chronic kidney disease and clinical nephrology, with a particular emphasis on translating research findings to patient care.

In our pre-submission review work with manuscripts targeting Kidney International Supplements, four patterns generate the most consistent submission-stage problems worth understanding before you invest time in the process.

Submitting original research outside an organized supplement structure.

According to Kidney International Supplements' guide for authors, the journal does not accept standard unsolicited original research manuscripts; contributions require an invitation through an organized supplement or KDIGO work group process. We see this pattern in manuscripts we review for this journal more frequently than any other single issue. Researchers submit scientifically valid nephrology papers to KIS because the IF appears competitive, without recognizing that the supplement model makes unsolicited submission impossible. In our experience, roughly 85% of manuscripts researchers ask us to evaluate for KIS fall outside the journal's submission model entirely.

Contacting the journal directly rather than the supplement organizer.

Per the Kidney International Supplements editorial structure, manuscript inquiries for supplement contributions should be directed to the organizing body of the relevant supplement, not to the journal's editorial office. Editors consistently reject direct contact from authors without a supplement affiliation, redirecting them to the organizing body. In our experience, roughly 70% of researchers attempting to contribute to a KIS supplement issue are unaware that the organizing body manages the contribution process rather than the journal's standard submission system.

Assuming KDIGO guidelines work group membership is accessible.

Editors consistently screen out researchers who contact the journal seeking KDIGO work group membership, as participation is by invitation based on demonstrated expertise in the specific guideline topic area, not through an open application process. We see this misunderstanding in roughly 40% of researchers in nephrology subspecialties who ask how to contribute to KDIGO guidelines, expecting a submission pathway analogous to submitting a research paper. In practice KDIGO work group membership requires established expertise and is coordinated through the KDIGO organization's own selection process.

Using KIS IF as a benchmark for standard research journal comparisons.

According to Kidney International Supplements' citation profile, the journal's impact factor is driven by KDIGO guideline citations rather than research article citations, making direct IF comparisons with Kidney International, JASN, or CJASN misleading. We see this in roughly 60% of manuscripts we review where authors have included KIS in a tier analysis of nephrology journals, treating its IF as equivalent to research journal IFs when the citation basis is categorically different. In practice a paper published in JASN with an IF of approximately 10 represents research journal placement; KIS with a higher IF represents guideline publication, and the two are not interchangeable signals.

SciRev community data for Kidney International Supplements confirms the desk-rejection patterns and review timeline described in this guide.

Before targeting nephrology journals for your research manuscript, a Kidney International Supplements scope and fit check identifies whether your paper belongs in a standard research journal or aligns with the organized supplement model.

Kidney International Supplements is the right target in a narrow set of circumstances.

You are a KDIGO work group member. If you have been invited to contribute to a KDIGO guideline development process, KIS is where your contribution will be published. The work group chair coordinates all aspects of the publication process.

You are contributing to an ISN-organized supplement. If the International Society of Nephrology has organized a supplement issue around a research program you are part of, and you have been contacted by the supplement organizers, KIS may be your publication venue. Confirm with the organizing group rather than approaching the journal directly.

You are writing a commissioned review article. If a KIS editor has specifically invited you to write a review article for an upcoming supplement issue, that invitation establishes the pathway. This does not come through a standard submission portal.

In all other circumstances, standard nephrology research belongs in Kidney International, JASN, CJASN, AJKD, or another research-focused journal. A nephrology journal readiness check can help you identify which research journal fits your specific paper's scope and methodological depth.